 Glen Rock, N.J., Jan. 12, 2023 GLOBE NEWSWIRE RespireRx Pharmaceuticals Inc. OTC Markets: RSPI RespireRx or the Company, a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce that, on January 11, 2023, it established ResolutionRx Ltd ResolutionRx, a... The post RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cann... 